Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Selection, Genetic | 25 | 2019 | 502 | 4.630 |
Why?
|
Genetic Variation | 36 | 2018 | 1349 | 3.620 |
Why?
|
Genetics, Population | 20 | 2018 | 394 | 3.150 |
Why?
|
Glucuronosyltransferase | 12 | 2014 | 184 | 3.100 |
Why?
|
Polymorphism, Single Nucleotide | 38 | 2018 | 2350 | 2.800 |
Why?
|
Gene Frequency | 34 | 2019 | 676 | 2.710 |
Why?
|
Haplotypes | 20 | 2019 | 642 | 2.560 |
Why?
|
Adaptation, Physiological | 9 | 2022 | 306 | 2.460 |
Why?
|
Glucocorticoids | 7 | 2014 | 347 | 2.060 |
Why?
|
Linkage Disequilibrium | 18 | 2013 | 473 | 1.860 |
Why?
|
Genome, Human | 12 | 2018 | 756 | 1.680 |
Why?
|
Gene Expression Regulation | 11 | 2017 | 1917 | 1.620 |
Why?
|
Transcription, Genetic | 6 | 2017 | 1135 | 1.540 |
Why?
|
Acclimatization | 5 | 2018 | 76 | 1.540 |
Why?
|
Models, Genetic | 17 | 2019 | 926 | 1.540 |
Why?
|
Polymorphism, Genetic | 17 | 2012 | 819 | 1.450 |
Why?
|
Alleles | 20 | 2018 | 1127 | 1.370 |
Why?
|
Evolution, Molecular | 10 | 2015 | 813 | 1.270 |
Why?
|
Allelic Imbalance | 3 | 2013 | 20 | 1.220 |
Why?
|
Calcitriol | 3 | 2017 | 174 | 1.110 |
Why?
|
Gene Flow | 7 | 2017 | 88 | 1.080 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 196 | 1.080 |
Why?
|
Recombination, Genetic | 6 | 2014 | 439 | 1.000 |
Why?
|
Altitude | 6 | 2022 | 40 | 0.950 |
Why?
|
Multigene Family | 7 | 2014 | 202 | 0.950 |
Why?
|
Phenotype | 12 | 2016 | 2375 | 0.930 |
Why?
|
Multifactorial Inheritance | 2 | 2018 | 158 | 0.930 |
Why?
|
Genotype | 21 | 2018 | 1850 | 0.920 |
Why?
|
Humans | 111 | 2022 | 86281 | 0.920 |
Why?
|
Transcriptome | 5 | 2016 | 574 | 0.910 |
Why?
|
Climate | 4 | 2011 | 50 | 0.890 |
Why?
|
Human Migration | 3 | 2019 | 25 | 0.870 |
Why?
|
Skin Pigmentation | 3 | 2019 | 40 | 0.870 |
Why?
|
Breast | 5 | 2011 | 286 | 0.860 |
Why?
|
Sequence Analysis, DNA | 11 | 2018 | 853 | 0.860 |
Why?
|
DNA, Ancient | 2 | 2019 | 18 | 0.850 |
Why?
|
Genetic Predisposition to Disease | 13 | 2017 | 2267 | 0.850 |
Why?
|
Genome-Wide Association Study | 8 | 2018 | 1611 | 0.830 |
Why?
|
Adaptation, Biological | 2 | 2014 | 85 | 0.810 |
Why?
|
Environment | 3 | 2014 | 219 | 0.800 |
Why?
|
Phylogeny | 11 | 2016 | 1136 | 0.760 |
Why?
|
Lymphocytes | 2 | 2013 | 461 | 0.760 |
Why?
|
Breast Neoplasms | 7 | 2014 | 2881 | 0.740 |
Why?
|
Calpain | 3 | 2005 | 111 | 0.700 |
Why?
|
Receptors, Glucocorticoid | 4 | 2014 | 117 | 0.650 |
Why?
|
Biological Evolution | 7 | 2011 | 917 | 0.640 |
Why?
|
Hemoglobins | 3 | 2018 | 179 | 0.620 |
Why?
|
Diet | 2 | 2010 | 442 | 0.600 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 165 | 0.580 |
Why?
|
Tibet | 6 | 2022 | 19 | 0.570 |
Why?
|
Bayes Theorem | 6 | 2019 | 360 | 0.570 |
Why?
|
Base Sequence | 16 | 2011 | 2329 | 0.540 |
Why?
|
Population Density | 4 | 2019 | 60 | 0.540 |
Why?
|
Hominidae | 4 | 2015 | 95 | 0.540 |
Why?
|
Lipopolysaccharides | 2 | 2016 | 285 | 0.540 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2006 | 79 | 0.520 |
Why?
|
Genetic Markers | 6 | 2014 | 476 | 0.510 |
Why?
|
Monocytes | 1 | 2016 | 214 | 0.510 |
Why?
|
Mutation | 12 | 2011 | 3952 | 0.510 |
Why?
|
Vitamin D | 2 | 2017 | 261 | 0.510 |
Why?
|
Hypoxia | 3 | 2018 | 638 | 0.500 |
Why?
|
Dexamethasone | 3 | 2014 | 326 | 0.490 |
Why?
|
Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2014 | 3 | 0.490 |
Why?
|
Cell Proliferation | 3 | 2016 | 1571 | 0.490 |
Why?
|
Biomarkers, Pharmacological | 1 | 2014 | 22 | 0.480 |
Why?
|
Cytochrome P-450 CYP3A | 3 | 2008 | 43 | 0.470 |
Why?
|
DNA | 8 | 2017 | 1293 | 0.470 |
Why?
|
Hylobates | 1 | 2013 | 4 | 0.460 |
Why?
|
Molecular Sequence Data | 13 | 2011 | 3029 | 0.440 |
Why?
|
Primates | 3 | 2005 | 151 | 0.430 |
Why?
|
Arthritis, Rheumatoid | 1 | 2014 | 163 | 0.430 |
Why?
|
Binding Sites | 6 | 2016 | 1098 | 0.430 |
Why?
|
DNA, Complementary | 1 | 2013 | 393 | 0.420 |
Why?
|
Gene Expression Profiling | 7 | 2017 | 1381 | 0.420 |
Why?
|
Animals | 28 | 2016 | 26518 | 0.420 |
Why?
|
Liver | 4 | 2011 | 1229 | 0.420 |
Why?
|
Enhancer Elements, Genetic | 3 | 2011 | 266 | 0.410 |
Why?
|
Quantitative Trait Loci | 6 | 2017 | 576 | 0.410 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 302 | 0.410 |
Why?
|
Chromosome Mapping | 8 | 2016 | 1074 | 0.400 |
Why?
|
Duffy Blood-Group System | 2 | 2001 | 7 | 0.400 |
Why?
|
Interleukin-6 | 2 | 2014 | 255 | 0.390 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 92 | 0.390 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2011 | 45 | 0.390 |
Why?
|
Gene-Environment Interaction | 1 | 2012 | 103 | 0.390 |
Why?
|
Cold Climate | 1 | 2010 | 4 | 0.390 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2015 | 546 | 0.390 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.380 |
Why?
|
Mammography | 1 | 2014 | 460 | 0.380 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 154 | 0.380 |
Why?
|
Body Temperature Regulation | 1 | 2010 | 56 | 0.380 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 339 | 0.380 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 12 | 0.370 |
Why?
|
Italy | 9 | 2011 | 106 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2005 | 1372 | 0.370 |
Why?
|
Female | 31 | 2018 | 44405 | 0.370 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2016 | 148 | 0.360 |
Why?
|
NF-kappa B | 1 | 2013 | 442 | 0.360 |
Why?
|
Gene Expression | 4 | 2013 | 1281 | 0.360 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 123 | 0.350 |
Why?
|
Protein Binding | 4 | 2016 | 1454 | 0.350 |
Why?
|
Africa | 7 | 2011 | 98 | 0.350 |
Why?
|
Thalassemia | 9 | 1991 | 16 | 0.340 |
Why?
|
Nepal | 6 | 2022 | 14 | 0.340 |
Why?
|
Microsatellite Repeats | 2 | 2000 | 141 | 0.340 |
Why?
|
Ion Channels | 1 | 2010 | 245 | 0.340 |
Why?
|
Europe | 6 | 2019 | 308 | 0.330 |
Why?
|
Genome | 3 | 2022 | 371 | 0.330 |
Why?
|
Alternative Splicing | 1 | 2009 | 201 | 0.310 |
Why?
|
Metabolic Diseases | 1 | 2008 | 48 | 0.310 |
Why?
|
Genomics | 5 | 2016 | 710 | 0.310 |
Why?
|
Computational Biology | 4 | 2016 | 528 | 0.300 |
Why?
|
alpha 1-Antitrypsin | 1 | 2006 | 16 | 0.300 |
Why?
|
Asthma | 2 | 2014 | 947 | 0.300 |
Why?
|
Pseudogenes | 1 | 2006 | 35 | 0.300 |
Why?
|
Genetic Heterogeneity | 2 | 2015 | 62 | 0.290 |
Why?
|
Spermatozoa | 1 | 2006 | 61 | 0.290 |
Why?
|
Polymerase Chain Reaction | 6 | 2005 | 927 | 0.290 |
Why?
|
B-Lymphocytes | 1 | 2011 | 724 | 0.290 |
Why?
|
Species Specificity | 5 | 2016 | 678 | 0.280 |
Why?
|
Receptors, Steroid | 1 | 2005 | 42 | 0.270 |
Why?
|
Genetic Linkage | 4 | 2005 | 623 | 0.270 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 129 | 0.260 |
Why?
|
DNA Primers | 4 | 2005 | 542 | 0.260 |
Why?
|
Pan troglodytes | 5 | 2013 | 197 | 0.260 |
Why?
|
Water-Electrolyte Balance | 1 | 2004 | 66 | 0.250 |
Why?
|
Prion Diseases | 1 | 2004 | 32 | 0.250 |
Why?
|
Prions | 1 | 2004 | 54 | 0.250 |
Why?
|
Beta-Globulins | 1 | 2003 | 4 | 0.240 |
Why?
|
DNA, Mitochondrial | 5 | 2017 | 183 | 0.240 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 114 | 0.240 |
Why?
|
Proteins | 1 | 2009 | 777 | 0.230 |
Why?
|
Cell Line | 4 | 2013 | 2466 | 0.230 |
Why?
|
Male | 23 | 2017 | 40860 | 0.230 |
Why?
|
Promoter Regions, Genetic | 4 | 2002 | 937 | 0.220 |
Why?
|
Transcription Factors | 4 | 2013 | 1555 | 0.220 |
Why?
|
Cluster Analysis | 3 | 2016 | 369 | 0.210 |
Why?
|
Time Factors | 6 | 2019 | 5198 | 0.210 |
Why?
|
Geography | 4 | 2010 | 223 | 0.210 |
Why?
|
Gene Conversion | 1 | 2001 | 25 | 0.210 |
Why?
|
Likelihood Functions | 4 | 2017 | 251 | 0.200 |
Why?
|
Demography | 2 | 2002 | 177 | 0.190 |
Why?
|
Dogs | 3 | 2014 | 684 | 0.190 |
Why?
|
Chromosome Deletion | 5 | 1990 | 228 | 0.190 |
Why?
|
Regulatory-Associated Protein of mTOR | 2 | 2010 | 11 | 0.190 |
Why?
|
Genetics, Medical | 1 | 2000 | 52 | 0.180 |
Why?
|
Globins | 8 | 1990 | 31 | 0.180 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 133 | 0.180 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 286 | 0.180 |
Why?
|
Principal Component Analysis | 2 | 2017 | 155 | 0.180 |
Why?
|
Middle Aged | 9 | 2018 | 24957 | 0.180 |
Why?
|
Young Adult | 6 | 2015 | 5961 | 0.180 |
Why?
|
Sequence Deletion | 2 | 2015 | 205 | 0.180 |
Why?
|
Temperature | 2 | 2011 | 395 | 0.180 |
Why?
|
Population | 2 | 2015 | 35 | 0.170 |
Why?
|
Adult | 14 | 2018 | 25577 | 0.170 |
Why?
|
DNA, Satellite | 2 | 1998 | 18 | 0.170 |
Why?
|
Indians, South American | 1 | 2018 | 5 | 0.170 |
Why?
|
Membrane Glycoproteins | 1 | 2001 | 428 | 0.170 |
Why?
|
Immediate-Early Proteins | 2 | 2011 | 164 | 0.170 |
Why?
|
Siberia | 2 | 2015 | 12 | 0.170 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 100 | 0.170 |
Why?
|
Emigration and Immigration | 3 | 2012 | 48 | 0.160 |
Why?
|
Sequence Alignment | 2 | 2011 | 351 | 0.160 |
Why?
|
Genetic Drift | 1 | 2017 | 37 | 0.160 |
Why?
|
Genetic Diseases, Inborn | 1 | 1998 | 101 | 0.160 |
Why?
|
Ethiopia | 4 | 2013 | 37 | 0.150 |
Why?
|
Germ-Line Mutation | 1 | 2000 | 329 | 0.150 |
Why?
|
Uridine Phosphorylase | 1 | 2017 | 4 | 0.150 |
Why?
|
Energy Metabolism | 2 | 2010 | 271 | 0.150 |
Why?
|
Origin of Life | 1 | 2016 | 4 | 0.150 |
Why?
|
Population Surveillance | 1 | 1998 | 219 | 0.150 |
Why?
|
Drosophila Proteins | 1 | 2001 | 486 | 0.150 |
Why?
|
Mutation Rate | 1 | 2016 | 48 | 0.140 |
Why?
|
Nucleotide Motifs | 1 | 2016 | 47 | 0.140 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1996 | 37 | 0.140 |
Why?
|
Cell Line, Tumor | 3 | 2013 | 2421 | 0.140 |
Why?
|
Russia | 1 | 2015 | 25 | 0.140 |
Why?
|
Adaptive Immunity | 2 | 2014 | 164 | 0.140 |
Why?
|
Endothelial Cells | 1 | 2018 | 427 | 0.140 |
Why?
|
Australia | 2 | 2016 | 99 | 0.140 |
Why?
|
Japan | 1 | 2015 | 307 | 0.130 |
Why?
|
Genetic Association Studies | 2 | 2014 | 294 | 0.130 |
Why?
|
Nigeria | 2 | 2013 | 152 | 0.130 |
Why?
|
Mifepristone | 1 | 2014 | 33 | 0.130 |
Why?
|
Gene Duplication | 1 | 2015 | 125 | 0.130 |
Why?
|
Pharmacogenetics | 2 | 2014 | 434 | 0.120 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 171 | 0.120 |
Why?
|
Cameroon | 2 | 2005 | 14 | 0.120 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1994 | 19 | 0.120 |
Why?
|
RNA, Messenger | 2 | 2011 | 1975 | 0.120 |
Why?
|
Albumins | 1 | 2014 | 133 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 347 | 0.120 |
Why?
|
Octamer Transcription Factor-1 | 2 | 2010 | 17 | 0.120 |
Why?
|
Brain Ischemia | 1 | 2018 | 397 | 0.120 |
Why?
|
Fourier Analysis | 1 | 2014 | 125 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1994 | 135 | 0.120 |
Why?
|
Cells, Cultured | 2 | 2016 | 2810 | 0.120 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2013 | 13 | 0.120 |
Why?
|
Electron Transport | 1 | 2013 | 71 | 0.120 |
Why?
|
Aged, 80 and over | 2 | 2018 | 6481 | 0.120 |
Why?
|
History, Ancient | 3 | 2022 | 74 | 0.120 |
Why?
|
Colon | 1 | 2017 | 495 | 0.120 |
Why?
|
Models, Biological | 2 | 2011 | 1748 | 0.120 |
Why?
|
Immunity, Innate | 2 | 2014 | 405 | 0.120 |
Why?
|
Colonic Neoplasms | 1 | 1998 | 554 | 0.120 |
Why?
|
China | 2 | 2005 | 228 | 0.120 |
Why?
|
Genetic Loci | 2 | 2015 | 250 | 0.110 |
Why?
|
Chromosomes, Fungal | 1 | 1993 | 15 | 0.110 |
Why?
|
Vitamins | 1 | 2013 | 81 | 0.110 |
Why?
|
Altitude Sickness | 1 | 2012 | 10 | 0.110 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 132 | 0.110 |
Why?
|
Drug Synergism | 1 | 2013 | 303 | 0.110 |
Why?
|
Algorithms | 2 | 2014 | 1828 | 0.110 |
Why?
|
Pongo pygmaeus | 3 | 2001 | 9 | 0.110 |
Why?
|
Hemoglobin H | 3 | 1987 | 3 | 0.110 |
Why?
|
HIV-1 | 1 | 1994 | 163 | 0.110 |
Why?
|
Gene Library | 1 | 1993 | 130 | 0.110 |
Why?
|
Paclitaxel | 1 | 2014 | 460 | 0.110 |
Why?
|
Indians, North American | 1 | 2012 | 48 | 0.110 |
Why?
|
Computer Simulation | 2 | 2015 | 1077 | 0.110 |
Why?
|
CpG Islands | 1 | 2012 | 150 | 0.110 |
Why?
|
Coyotes | 1 | 2011 | 5 | 0.110 |
Why?
|
Extinction, Biological | 1 | 2013 | 85 | 0.110 |
Why?
|
Wolves | 1 | 2011 | 10 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2011 | 173 | 0.100 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2011 | 8 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2013 | 407 | 0.100 |
Why?
|
Homozygote | 3 | 2010 | 200 | 0.100 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2011 | 41 | 0.100 |
Why?
|
HapMap Project | 1 | 2011 | 47 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 244 | 0.100 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 352 | 0.100 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 153 | 0.100 |
Why?
|
Crohn Disease | 2 | 2015 | 729 | 0.100 |
Why?
|
Pilot Projects | 1 | 2014 | 837 | 0.100 |
Why?
|
Meiosis | 1 | 2011 | 80 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 30 | 0.100 |
Why?
|
Retinoids | 1 | 2010 | 17 | 0.100 |
Why?
|
T-Lymphocytes | 2 | 2014 | 1195 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 291 | 0.100 |
Why?
|
Tetrahydronaphthalenes | 1 | 2010 | 15 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2011 | 416 | 0.100 |
Why?
|
Colitis, Ulcerative | 2 | 2015 | 708 | 0.100 |
Why?
|
Retinoid X Receptors | 1 | 2010 | 39 | 0.100 |
Why?
|
Uncoupling Protein 3 | 1 | 2010 | 9 | 0.100 |
Why?
|
Uncoupling Protein 2 | 1 | 2010 | 11 | 0.100 |
Why?
|
Lymphocyte Activation | 1 | 1994 | 727 | 0.100 |
Why?
|
Transcription Initiation Site | 1 | 2010 | 45 | 0.100 |
Why?
|
Hep G2 Cells | 1 | 2010 | 48 | 0.100 |
Why?
|
Benzoates | 1 | 2010 | 44 | 0.100 |
Why?
|
Uncoupling Protein 1 | 1 | 2010 | 35 | 0.100 |
Why?
|
Trans-Activators | 1 | 2013 | 429 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2011 | 280 | 0.100 |
Why?
|
Adenocarcinoma | 1 | 1998 | 1160 | 0.100 |
Why?
|
Databases, Factual | 1 | 2014 | 808 | 0.090 |
Why?
|
Culture | 1 | 2010 | 53 | 0.090 |
Why?
|
Camptothecin | 2 | 2002 | 189 | 0.090 |
Why?
|
Hemoglobins, Abnormal | 2 | 1986 | 5 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 193 | 0.090 |
Why?
|
Pigmentation | 1 | 2010 | 69 | 0.090 |
Why?
|
Aged | 4 | 2018 | 18353 | 0.090 |
Why?
|
Databases, Genetic | 1 | 2011 | 259 | 0.090 |
Why?
|
Ecology | 1 | 2010 | 74 | 0.090 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2010 | 41 | 0.090 |
Why?
|
Software | 1 | 2014 | 650 | 0.090 |
Why?
|
Precision Medicine | 1 | 2014 | 394 | 0.090 |
Why?
|
Stroke | 1 | 2018 | 959 | 0.090 |
Why?
|
Base Pairing | 2 | 2006 | 55 | 0.090 |
Why?
|
Odds Ratio | 1 | 2011 | 677 | 0.090 |
Why?
|
Founder Effect | 2 | 2000 | 104 | 0.090 |
Why?
|
Organ Specificity | 1 | 2010 | 257 | 0.090 |
Why?
|
Down-Regulation | 1 | 2010 | 504 | 0.090 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 268 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 1196 | 0.080 |
Why?
|
Midazolam | 1 | 2008 | 48 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 380 | 0.080 |
Why?
|
Homeostasis | 1 | 2010 | 408 | 0.080 |
Why?
|
Antiporters | 1 | 2008 | 18 | 0.080 |
Why?
|
DNA Methylation | 1 | 2012 | 622 | 0.080 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 2062 | 0.080 |
Why?
|
Signal Transduction | 3 | 2013 | 3233 | 0.080 |
Why?
|
Asia | 3 | 2012 | 94 | 0.080 |
Why?
|
Ecosystem | 1 | 2010 | 315 | 0.080 |
Why?
|
Phylogeography | 2 | 2017 | 41 | 0.070 |
Why?
|
Serpins | 1 | 2006 | 29 | 0.070 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1986 | 79 | 0.070 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 49 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 877 | 0.070 |
Why?
|
Transfection | 1 | 2008 | 895 | 0.070 |
Why?
|
Case-Control Studies | 1 | 2011 | 1801 | 0.070 |
Why?
|
Glucokinase | 1 | 2006 | 61 | 0.070 |
Why?
|
Monte Carlo Method | 2 | 2010 | 185 | 0.070 |
Why?
|
Metabolic Syndrome | 1 | 2008 | 141 | 0.070 |
Why?
|
Birth Weight | 1 | 2006 | 144 | 0.070 |
Why?
|
Papio | 1 | 2006 | 82 | 0.070 |
Why?
|
Risk Factors | 3 | 2015 | 5397 | 0.070 |
Why?
|
Mice | 2 | 2011 | 11313 | 0.070 |
Why?
|
Los Angeles | 1 | 2004 | 28 | 0.060 |
Why?
|
Mexican Americans | 1 | 2005 | 63 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2004 | 86 | 0.060 |
Why?
|
Mutagenesis | 2 | 2001 | 199 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2004 | 210 | 0.060 |
Why?
|
Protein Conformation | 1 | 2006 | 881 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 1671 | 0.060 |
Why?
|
India | 2 | 2017 | 120 | 0.060 |
Why?
|
Bilirubin | 2 | 2002 | 124 | 0.060 |
Why?
|
Microsomes, Liver | 1 | 2002 | 49 | 0.060 |
Why?
|
Blood Glucose | 1 | 2006 | 873 | 0.050 |
Why?
|
Pakistan | 1 | 2001 | 15 | 0.050 |
Why?
|
Haplorhini | 1 | 2002 | 81 | 0.050 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2002 | 85 | 0.050 |
Why?
|
Base Composition | 1 | 2001 | 35 | 0.050 |
Why?
|
Pan paniscus | 1 | 2001 | 10 | 0.050 |
Why?
|
Crossing Over, Genetic | 1 | 2001 | 33 | 0.050 |
Why?
|
Receptors, Interleukin-4 | 1 | 2001 | 9 | 0.050 |
Why?
|
DNA Restriction Enzymes | 5 | 1989 | 98 | 0.050 |
Why?
|
Gorilla gorilla | 1 | 2001 | 40 | 0.050 |
Why?
|
Sample Size | 1 | 2001 | 130 | 0.050 |
Why?
|
Gene Pool | 1 | 2000 | 6 | 0.050 |
Why?
|
Toll-Like Receptor 4 | 1 | 2001 | 88 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 203 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2001 | 92 | 0.050 |
Why?
|
HLA Antigens | 1 | 2002 | 232 | 0.050 |
Why?
|
Biomarkers, Tumor | 1 | 2008 | 1461 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2014 | 8431 | 0.050 |
Why?
|
Plasmodium vivax | 1 | 2000 | 1 | 0.050 |
Why?
|
Amino Acids | 1 | 2001 | 252 | 0.050 |
Why?
|
Africa South of the Sahara | 1 | 2000 | 21 | 0.050 |
Why?
|
Dinucleotide Repeats | 1 | 1999 | 13 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 689 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 4 | 1993 | 245 | 0.040 |
Why?
|
Rats | 1 | 2006 | 3984 | 0.040 |
Why?
|
Human Genome Project | 1 | 1998 | 19 | 0.040 |
Why?
|
Hemoglobinopathies | 2 | 1989 | 10 | 0.040 |
Why?
|
Hepatitis B | 2 | 1989 | 72 | 0.040 |
Why?
|
Fetal Hemoglobin | 2 | 1989 | 14 | 0.040 |
Why?
|
Whole Genome Sequencing | 1 | 2018 | 76 | 0.040 |
Why?
|
Blotting, Southern | 2 | 1996 | 129 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2018 | 93 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 1998 | 66 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 197 | 0.040 |
Why?
|
Myanmar | 1 | 2017 | 3 | 0.040 |
Why?
|
Population Dynamics | 1 | 2018 | 130 | 0.040 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 77 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 276 | 0.040 |
Why?
|
United States | 3 | 2017 | 6637 | 0.040 |
Why?
|
Genetic Testing | 2 | 1998 | 535 | 0.040 |
Why?
|
Middle East | 2 | 2000 | 17 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2017 | 22 | 0.040 |
Why?
|
New Guinea | 1 | 2016 | 1 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2017 | 134 | 0.040 |
Why?
|
Neanderthals | 1 | 2016 | 15 | 0.040 |
Why?
|
Paleodontology | 1 | 2016 | 11 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2016 | 71 | 0.040 |
Why?
|
DNA, Recombinant | 1 | 1996 | 67 | 0.030 |
Why?
|
Chromatin | 1 | 2018 | 378 | 0.030 |
Why?
|
Leukocytes | 1 | 2017 | 202 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1995 | 48 | 0.030 |
Why?
|
Hemodynamics | 1 | 2018 | 710 | 0.030 |
Why?
|
Goats | 1 | 2014 | 18 | 0.030 |
Why?
|
Canidae | 1 | 2014 | 5 | 0.030 |
Why?
|
Spermatocytes | 1 | 2014 | 8 | 0.030 |
Why?
|
Phytohemagglutinins | 1 | 2014 | 22 | 0.030 |
Why?
|
Sheep | 1 | 2014 | 238 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2014 | 78 | 0.030 |
Why?
|
CD3 Complex | 1 | 2014 | 135 | 0.030 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1994 | 2 | 0.030 |
Why?
|
Gene Products, env | 1 | 1994 | 5 | 0.030 |
Why?
|
CD28 Antigens | 1 | 2014 | 88 | 0.030 |
Why?
|
Hepcidins | 1 | 2013 | 4 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2013 | 31 | 0.030 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1990 | 147 | 0.030 |
Why?
|
Ferritins | 1 | 2013 | 29 | 0.030 |
Why?
|
Drug Resistance | 1 | 2014 | 256 | 0.030 |
Why?
|
Protein Precursors | 1 | 1994 | 143 | 0.030 |
Why?
|
Erythropoietin | 1 | 2013 | 91 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 77 | 0.030 |
Why?
|
Biopsy | 1 | 2017 | 1160 | 0.030 |
Why?
|
Hepatitis B Antibodies | 2 | 1989 | 15 | 0.030 |
Why?
|
Americas | 1 | 2012 | 19 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1993 | 274 | 0.030 |
Why?
|
Mammals | 1 | 2014 | 227 | 0.030 |
Why?
|
Gene Amplification | 1 | 1993 | 131 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 376 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2000 | 924 | 0.030 |
Why?
|
X Chromosome | 1 | 1993 | 152 | 0.030 |
Why?
|
Cell Cycle | 1 | 1994 | 502 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 1994 | 1014 | 0.030 |
Why?
|
Genetic Vectors | 1 | 1993 | 438 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1994 | 337 | 0.020 |
Why?
|
Introns | 2 | 2007 | 289 | 0.020 |
Why?
|
Malaria | 1 | 1991 | 23 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2013 | 997 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 1208 | 0.020 |
Why?
|
Space-Time Clustering | 2 | 1988 | 3 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
Biomarkers | 2 | 2014 | 1709 | 0.020 |
Why?
|
Hepatitis B e Antigens | 1 | 1989 | 8 | 0.020 |
Why?
|
Cohort Studies | 1 | 2017 | 2759 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 125 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 1989 | 42 | 0.020 |
Why?
|
Egypt | 3 | 1999 | 13 | 0.020 |
Why?
|
Carrier State | 1 | 1989 | 39 | 0.020 |
Why?
|
Placenta | 1 | 1991 | 173 | 0.020 |
Why?
|
Neurosecretory Systems | 1 | 2009 | 35 | 0.020 |
Why?
|
DNA, Viral | 1 | 1989 | 265 | 0.020 |
Why?
|
Anemia, Sickle Cell | 2 | 1990 | 131 | 0.020 |
Why?
|
Taste | 1 | 2008 | 28 | 0.020 |
Why?
|
Internet | 1 | 2010 | 309 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2009 | 226 | 0.020 |
Why?
|
Prevalence | 2 | 2008 | 1239 | 0.020 |
Why?
|
Africa, Northern | 1 | 1986 | 5 | 0.020 |
Why?
|
Macular Degeneration | 1 | 2008 | 58 | 0.020 |
Why?
|
Greece | 1 | 1986 | 19 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2006 | 22 | 0.020 |
Why?
|
Fasting | 1 | 2006 | 161 | 0.020 |
Why?
|
Risk | 1 | 2007 | 673 | 0.020 |
Why?
|
Sickle Cell Trait | 1 | 1986 | 21 | 0.020 |
Why?
|
Exons | 1 | 2007 | 450 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1985 | 49 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2008 | 243 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2006 | 2369 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2434 | 0.020 |
Why?
|
Pregnancy | 1 | 1991 | 2885 | 0.010 |
Why?
|
Glucuronides | 1 | 2002 | 34 | 0.010 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2002 | 33 | 0.010 |
Why?
|
Phenobarbital | 1 | 2002 | 33 | 0.010 |
Why?
|
Africa, Western | 1 | 2002 | 10 | 0.010 |
Why?
|
HLA-G Antigens | 1 | 2002 | 52 | 0.010 |
Why?
|
Extrachromosomal Inheritance | 1 | 2000 | 5 | 0.010 |
Why?
|
Adolescent | 5 | 1998 | 8968 | 0.010 |
Why?
|
Protein Subunits | 1 | 2001 | 122 | 0.010 |
Why?
|
Databases as Topic | 1 | 2000 | 92 | 0.010 |
Why?
|
Sudan | 1 | 1999 | 13 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 1139 | 0.010 |
Why?
|
Cuba | 2 | 1990 | 5 | 0.010 |
Why?
|
Consanguinity | 1 | 1998 | 73 | 0.010 |
Why?
|
Child | 2 | 2006 | 6913 | 0.010 |
Why?
|
Bronchial Hyperreactivity | 1 | 1998 | 77 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1999 | 526 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 1708 | 0.010 |
Why?
|
Finland | 1 | 1995 | 29 | 0.010 |
Why?
|
Codon | 1 | 1993 | 124 | 0.010 |
Why?
|
Child, Preschool | 1 | 1998 | 3608 | 0.010 |
Why?
|
Electrophoresis, Cellulose Acetate | 1 | 1991 | 3 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 1991 | 47 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1989 | 155 | 0.010 |
Why?
|
Erythrocytes | 1 | 1991 | 255 | 0.010 |
Why?
|
Heterozygote | 1 | 1991 | 365 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1990 | 104 | 0.010 |
Why?
|
Hepatitis B Antigens | 1 | 1988 | 2 | 0.010 |
Why?
|
Pedigree | 1 | 1989 | 966 | 0.000 |
Why?
|
Military Personnel | 1 | 1988 | 85 | 0.000 |
Why?
|
Hemoglobin, Sickle | 1 | 1986 | 19 | 0.000 |
Why?
|